|
KMID : 0384320090300030197
|
|
Korean Journal of Family Medicine
2009 Volume.30 No. 3 p.197 ~ p.202
|
|
|
Change of Selection to Antihypertensive Drugs in Hypertensive Patients with Diabetes Mellitus: In Pohang · Gyeongju Primary Care Research Network
|
|
Yun Zoo-Young
Lee Dong-Wook
Jeong Hwee-Soo
Park Ki-Heum
Lee Sin-Hyeung
Park Jung-Jae
Kim Dong-Ik
Ki Jae-Man
Cho Kyung-Rae
Song Joon-Seok
Choi Seok
U Cheang-Ho
Jung Tae-Ho
Kim Sung-Woo
Kim Ik
|
|
|
Abstract
|
|
|
Background: Angiotensin converting enzyme inhibitors (ACEIs) or Angiotensin II type 1 receptor blockers (ARBs) are compelling indication drugs for hypertensive patients with diabetes mellitus. But prescription rate in 2005 year study of Pohang · Gyeongju area was only 30.8%. Therefore, a study on the change of prescription rate in the same area after 3
years was done.
Methods: During three months from January 2008, 152 hypertensive patients with diabetes mellitus on their prescribed antihypertensive medications by 9 family physicians in visiting order were analyzed. After the analysis, the infl uencing factors for such prescriptions were ascertained by directly visiting each physicians who prescribed them.
Results: A regimen of 16 antihypertensive agents were prescribed by these family physicians. Prescription count of ACEIs or ARBs was 101 cases (66.4%). ACEIs single therapy was 19 cases (12.5%), ACEIs combination therapy was 7 cases (4.6%), ARBs single therapy was 31 cases (20.4%) and ARBs combination therapy was 44 cases (28.9%). The ACEIs or ARBs which were selected by physicians that followed "compelling indication" was 5 (55.6%), "excellent reduce pressure effect" was 3 (33.3%) and "public relations of new medicine" was 1 (11.1%).
Conclusion: In prescribing antihypertensive agents for patients with diabetes mellitus, selection of ACEIs or ARBs was increased from 30.8% to 66.4%. Education of recommended standard by participating in such study and developing of
excellent new medicines may increase such change.
|
|
|
KEYWORD
|
|
|
Diabetes Mellitus, Hypertension, Angiotensin Converting Enzyme Inhibitors, Angiotensin II Type 1 Receptor Blockers
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|